Okay, let's tackle this question. The user is asking which medication is beneficial for NSAID-induced gastric ulcers. First, I need to recall the core concept here. NSAIDs like ibuprofen or aspirin inhibit COX enzymes, which are responsible for producing prostaglandins. Prostaglandins protect the stomach lining by promoting mucus production and bicarbonate secretion. So when COX is inhibited, especially COX-1, there's a reduction in protective prostaglandins, leading to increased acid and decreased mucosal protection, causing ulcers.

Now, the correct answer would be a drug that can counteract this effect. PPIs (proton pump inhibitors) like omeprazole are the gold standard here. They work by irreversibly inhibiting the H+/K+ ATPase (proton pump) in parietal cells, reducing acid secretion. This helps the ulcer heal and protects the stomach lining. Alternatively, H2 blockers like ranitidine are also used, but PPIs are more effective for healing.

Looking at the options, the correct answer is likely a PPI. Let's say option C is omeprazole. The other options might be other drugs. For example, if option A is sucralfate, that's a cytoprotective agent forming a protective layer over the ulcer. But sucralfate isn't as effective as PPIs. Option B could be misoprostol, a synthetic prostaglandin analog that mimics the protective effects of prostaglandins by increasing mucus and bicarbonate. But misoprostol has side effects like diarrhea and isn't first-line. Option D might be an antacid, which provides temporary relief but doesn't heal ulcers.

So the clinical pearl here is that PPIs are the most effective for NSAID-induced ulcers. The key is to remember that COX inhibition leads to loss of protective prostaglandins, so agents that reduce acid (PPIs) or replace prostaglandins (misoprostol) are beneficial. But PPIs are preferred over H2 blockers or antacids. Also, stopping NSAIDs is crucial, but the question is about the beneficial medication.

**Core Concept**
NSAID-induced gastric ulcers result from inhibition of cyclooxygenase (COX) enzymes, particularly COX-1, which reduces protective gastric prostaglandins (e.g., PGE2, PGI2). These prostaglandins maintain mucosal blood flow, bicarbonate, and mucus secretion. Therapeutic strategies aim to restore mucosal defense or reduce acid secretion.

**Why the Correct Answer is Right**
**Proton pump inhibitors (PPIs)** like omeprazole irreversibly inhibit the H+/K+ ATPase (proton pump) in parietal cells, drastically reducing gastric acid secretion. This creates a less acidic environment, allowing ulcer healing and protecting the mucosa from further NSAID-induced injury. PPIs are first-line due to superior efficacy compared to H2-receptor antagonists or antacids.

**Why Each Wrong Option is Incorrect**
**Option A:** *Sucralfate* forms a protective coating over ulcers but does not address underlying acid secretion or prostaglandin deficiency.
**Option B:** *Misoprostol*, a PGE1

✓ Correct Answer: A. PGE1 agonist